BEIJING: China’s military has approved a coronavirus vaccine for use within its ranks that has been developed by its research unit and a biotech firm, the company said on Monday. Organisations around the world are racing to find ways to treat and prevent the deadly pathogen, which first emerged in the central Chinese city of Wuhan and has since killed over half a million people worldwide. More than half of 17 candidate vaccines identified by the World Health Organisation (WHO) that are in clinical evaluation involve Chinese companies or institutes. Hong Kong-listed CanSino Biologics said in a filing to the stock exchange that data from clinical trials showed the Chinese military vaccine had a “good safety profile” and potential to prevent disease caused by the novel coronavirus. CanSino said on Monday that China’s Central Military Commission approved the use of the vaccine on June 25, for one year. The vaccine was jointly developed by CanSino and the Beijing Institute of Biotechnology, part of the Academy of Military Medical Sciences. Its use cannot be expanded without further approvals, the listing said. It was not clear how widely it would be used within China’s enormous military forces, and the ministry of defence did not reply to an AFP request for further information. https://www.thenews.com.pk/print/679683-chinese-corona-vaccine-approved Does this mean strong buy on Chinese stock markets?????
CanSino Biologics Inc. (CanSinoBIO, stock 6185.HK) is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. Since its establishment in Tianjin, China in 2009, CanSinoBIO has experienced tremendous growth with now more than 450 employees, one approved vaccine for Ebola virus disease (Ad5-EBOV) and 16 vaccine candidates in the product pipeline. CanSinoBIO has been successfully listed on the Main Board of Hong Kong Exchange and Clearing Limited (HKEx) since March 2019. CanSinoBIO is focusing on continually expanding manufacturing capacity for its current vaccine candidates and further enhancing the competitiveness and the scope of its portfolio by promoting the R&D of new vaccine candidates. Leveraging broad experiences of our accomplished team of scientists and business leaders who had previously held technical and senior management positions at many of the leading pharmaceutical companies in the world, including Sanofi Pasteur, Astra Zeneca, Wyeth (now Pfizer) and CNBG (China), CanSinoBIO has developed four key platform technologies, including adenovirus-based viral vector vaccine, conjugation, protein structure design and recombination as well as vaccine formulation technologies. In addition, the company has in-licensed a number of new technologies and intellectual properties through collaborations with international research organizations and biotechnology companies. CanSinoBIO collaborates through partnerships with world-class academic centers or start-up companies that develop innovative technologies, to prepare the portfolio of the next decades and ensure sustainable growth of the company. CanSinoBIO is currently developing 16 vaccine candidates for 13 infectious disease areas, covering meningitis, pneumonia, tuberculosis, COVID-19, Ebola virus disease, pertussis, diphtheria, tetanus, shingles etc. Among these, Ad5-EBOV, the globally innovative Ebola virus disease vaccine, has received NDA (New Drug Application) approval in China in October 2017. The NDA applications of two meningococcal conjugate vaccines are under NMPA review. Moreover, Ad5-nCoV, the investigational vaccine against COVID-19 has been approved to enter into phase I clinical trial. At present, CanSinoBIO has seven vaccine candidates in the clinical trial stage or clinical trial application stage. There are also six pre-clinical vaccine candidates under development, including one combination vaccine candidate.
Hope it works and they sell it to Australia and NewZealand asap, got over a mate in Auss and Like to go climbing in NZ some time soon aswell. Could be worth Trillions, by the time they make enough Vaccines the rest of the world would of already had it so there sales targets are rapidly shrinking, but guess there media aren't tell people this so maybe sell it to people that have already had it just incase aswell.
I have a difficult time believing anything from the Chinese government these days. Freedom for Hong Kong!